Ovation.io — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Ovation.io operates at the intersection of digital health, AI/machine learning, and diagnostics, providing a critical data infrastructure layer for the precision medicine ecosystem. The company's core business involves curating and providing access to deeply phenotyped, disease-specific multi-omics data cohorts (e.g., for IBD, cardiometabolic diseases) to de-risk and accelerate therapeutic R&D for biopharma clients. Additionally, it offers a Laboratory Information Management System (Ovation LIMS) for clinical labs and operates a research network to mobilize remnant samples for research. Its strategy is validated through partnerships with major players like Illumina, DNAnexus, Datavant, and PrecisionLife.

Inflammatory Bowel DiseaseCardiometabolic DiseaseAutoimmune Disease

Technology Platform

Integrated platform for generating, linking, and providing access to multi-omics data (whole genome, transcriptome) with rich longitudinal clinical data. Includes Ovation LIMS for clinical lab operations and the Ovation Research Network for sample mobilization.

Opportunities

The rapid expansion of precision medicine into non-oncology therapeutic areas (e.g., cardiometabolic, autoimmune) creates massive demand for the deep, phenotypically-linked genomic datasets Ovation provides.

The explosive commercial and scientific interest in GLP-1 agonists presents a timely, high-value opportunity to establish a foundational dataset for understanding response and developing next-generation therapies.

Risk Factors

The company faces significant competition from larger, well-funded data aggregators and CROs, risking commoditization.

Its business model is also heavily dependent on securing patient data and samples in a complex, evolving regulatory environment, and proving a clear return on investment to biopharma clients whose research cycles are long and uncertain.

Competitive Landscape

Ovation competes in a fragmented market including large clinical research organizations (CROs) like IQVIA and LabCorp, genomic sequencing/service providers like Illumina and PacBio, and specialized real-world data/omics companies like Sema4, Tempus, and DNAnexus. Its differentiation lies in its specific focus on deep, tissue-level multi-omics linked to longitudinal clinical records and its dual-channel model engaging clinical labs.

More companies in Diagnostics & Precision Medicine →More companies in United States →